Patrick K Reville, MD¹, Hagop M. Kantarjian, MD², Gautam Borthakur, MD², Musa Yilmaz, MD³, Guillermo Montalban-Bravo, MD^2*, Courtney D. DiNardo, MD, MSc⁴, Michael Andreeff, MD, PhD⁵, Naval Daver, MD⁶, Nitin Jain, MD⁷, Steven M. Kornblau, MD⁵, Elias Jabbour, MD², Nicholas J. Short, MD², Yesid Alvarado, MD³, Maro Ohanian, DO^2*, Prithviraj Bose, MD², Lucia Masarova, MD^2*, Sa A Wang, MD^8*, Rebecca S. S Tidwell, MS^9*, Zeev E. Estrov, MD², Guillermo Garcia-Manero, MD², Marina Konopleva, MD, PhD², Farhad Ravandi, MBBS² and Tapan M. Kadia, MD¹⁰

¹Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
⁵Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
⁷Associate Professor of Medicine Department of Leukemia The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Jonathan A. Gutman, MD¹, Amanda Winters, MD, PhD², Maria L Amaya, MD, PhD¹, Christine M. McMahon, MD³, Jeffrey Schowinsky, MD^4*, Diana Abbott, PhD^5*, Andrew Hammes, MS^4*, Shanshan Pei, PhD^4*, Brett M. Stevens, PhD⁶, Craig T. Jordan, PhD⁷, Clayton Smith, MD¹ and Daniel A. Pollyea, MD⁸

¹Division of Hematology, University of Colorado, Denver, CO
²Department of Pediatrics, University of Colorado, Denver, CO
³Division of Hematology, University of Colorado, Aurora, CO
⁴University of Colorado, Aurora, CO
⁵Department of Biostatistics and Bioinformatics, University of Colorado Denver, Colorado Springs, CO
⁶Division of Hematology, Department of Medicine, University of Colorado, Aurora, CO
⁷Division of Hematology, Department of Medicine, Univ. of Colorado, Denver, Aurora, CO
⁸Division of Hematology, University of Colorado Denver, Aurora, CO

Jessica Liegel, MD¹, Richard M. Stone, MD², Robert J. Soiffer, MD³, Dina Stroopinsky, PhD^1*, Lina Bisharat^4*, Maryam Rahimian^4*, Emma Logan^4*, Pavania Elavalakanar, MSc, BSc^4*, Vincent T. Ho, MD^2*, Rizwan Romee, MD⁵, Donna S. Neuberg, ScD⁶, Yiwen Liu^6*, Lourdes M. Mendez, MD, PhD¹, Ajoy L. Dias, MD¹, Poorva Bindal, MD^1*, Anita Koshy, MD^1*, Shira Orr, PhD^1*, Daniela Torres^4*, Giulia Cheloni, PhD^1*, Benjamin L. Ebert, MD, PhD³, Donald Kufe, MD^2*, David E. Avigan, MD¹ and Jacalyn Rosenblatt, MD¹

¹Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
²Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Beth Israel Deaconess Medical Center, Boston, MA
⁵Dana-Farber Cancer Institute, Boston, MA
⁶Department of Data Science, Dana-Farber Cancer Institute, Boston, MA

Norbert Vey, MD¹, Corentin Orvain, MD, PhD^2*, Christian Recher, MD, PhD³, Arnaud Pigneux, MD, PhD^4*, Marc Bernard, MD^5*, Anne Banos, MD^6*, Pierre Peterlin, MD^7*, Sylvain Chantepie, MD^8*, Xavier Thomas, MD, PhD⁹, Cecile Pautas, MD^10,11*, Claude Gardin^12*, Emilie Lemasle, MD^13*, Emmanuel Raffoux, MD^14*, Romain Guieze, MD^15*, Chantal Himberlin, MD^16*, Clémence Loiseau, MD^17*, Amine Belhabri, MD^18*, Isabelle Luquet, MD^19*, Christine Terré, PharmD, PhD^20*, Martin Carre, MD^21*, Claude Preudhomme, MD, PhD²², Eric Delabesse, MD, PhD^23*, Karine Celli-Lebras, CRA^24*, Ariane C Mineur, CRA^25*, Jean-Francois Brasme, MD, PhD^26*, Jean Francois Hamel, MD^26*, Hervé Dombret, MD²⁷ and Mathilde Hunault, MD PhD^28,29*

¹Onco-Hematology Department, Paoli-Calmette Cancer Institute, Marseille, France
²CHRU, Angers, France, angers, France
³Service d'hématologie IUCT Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
⁴Bordeaux Haut-Leveque University Hospital, Pessac, France
⁵Clinical Hematology, Rennes Univeristy Hospital, Rennes, France
⁶HOPITAL, COTE BASQUE, France
⁷Clinical Hematology, HOPITAL HOTEL DIEU ET HME, NANTES CEDEX 1, France
⁸IHBN, CHU Caen, Caen, FRA
⁹Centre Hospitalier Universitaire de Lyon-Sud, Lyon, France
¹⁰Hopital Henri Mondor, AP-HP, Creteil, France
¹¹HOPITAL, CRETEIL, France
¹²Hematology, Avicenne Hospital, APHP, University Paris XIII, Bobigny, France
¹³Hematology Department, Henri-Becquerel Cancer Center, Rouen, France
¹⁴Hématologie clinique, Hôpital Saint-Louis, Paris, France
¹⁵CHU Estaing, Unit of adult cell therapy and clinical hematology, University Hospital of Clermont-Ferrand, Brookline, MA
¹⁶Hôpital Robert Debré, Reims, Reims, FRA
¹⁷University Versailles-Saint-Quentin-en-Yvelines, University Paris-Saclay, Paris Saclay, France
¹⁸Centre Leon Berard, Departement Oncologie Medicale, Lyon, France
¹⁹Hematology Biology, IUCT Oncopole Toulouse University Hospital, Toulouse, France
²⁰Laboratory of Hematology, André Mignot Hospital, Le Chesnay, France
²¹Hematology, CHU Grenoble Alpes, La Tronche, France
²²Centre de Biologie-Pathologie, CHU Lille, Lille, France
²³Hematology Laboratory, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
²⁴Saint-Louis University Hospital, Paris, France
²⁵Bordeaux University Hospital, Pessac, France
²⁶Centre de Recherche Clinique, CHU Angers, Angers, France
²⁷Division of Hematology, EA3518 Saint-Louis Institute for Research, Hôpital Saint-Louis, APHP, University of Paris, Paris, France, Paris, France
²⁸Clinical Hematology, Angers University Hospital, Angers, France
²⁹Université d'Angers, Inserm, CRCINA, Angers, France

Justin M. Watts, MD¹, Tara Lin, MD², Eunice S. Wang, MD³, Alice S. Mims, MD⁴, Elizabeth H. Cull, MD⁵, Prapti Patel, MD⁶, Paul J. Shami, MD^7*, Roland B. Walter, MD, PhD, MS⁸, Christopher R. Cogle⁹, Ruth A. Chenault, MS^10*, Bret Macpherson, MSc, MBA^10*, Allison Given Chunyk^10*, Catherine J. McMahan^10*, Jane A. Gross, PhD^10* and Scott Stromatt, MD^10*

¹University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
²University of Kansas Medical Center, Westwood, KS
³Roswell Park Comprehensive Cancer Center, BUFFALO, NY
⁴The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁵Cancer Institute, Prisma Health, Piedmont, SC
⁶Simmons Comprehensive Cancer Center, Harold C Simmons Comprehensive Cancer Center, Dallas, TX
⁷Huntsman Cancer Institute, Salt Lake City, UT
⁸Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁹University of Florida, Gainesville, FL
¹⁰Aptevo Therapeutics, Seattle, WA

Chaoke Bu, MD^1*, Zhiyong Peng, MD^1*, Min Luo, PhD^2*, Guangchao Li, PhD^3* and Chunfu Li, MD¹

¹Nanfang-Chunfu Children's Institute of Hematology & Oncology, Taixin Hospital, Dongguan, China
²Guangzhou Bio-gene, GUANGZHOU, China
³Guangzhou Bio-gene, Guangzhou, China

Qi Zhang, PhD^1*, Lina Han, PhD¹, Alessia Lodi, PhD^2*, Connie Weng^1*, Vinitha Mary Kuruvilla, MSc^1*, Antonio Cavazos, MSc^1*, Helen Ma, MS^1*, Abhishek Maiti^1*, Yoko Tabe, MD, PhD³, Joseph R Marszalek, PhD^4*, Stefano Tiziani^2* and Marina Konopleva, MD, PhD⁵

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Nutritional Sciences & Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX
³Department of Clinical Laboratory Medicine, Graduate School of Medicine, Juntendo University, Tokyo, Japan
⁴Institute for Applied Cancer Science and Center for Co-Clinical Trials, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX

Alice S. Mims, MD¹, Melhem Solh, MD², Uma Borate³, Naveen Pemmaraju, MD⁴, Gautam Borthakur, MD⁵, Gail J. Roboz, MD⁶, Ben Powell, PhD^7*, Paul Severson, PhD^7*, Bernice Matusow^7*, Jason Halladay, PhD^7*, Ching Hsu, PhD^8*, Paul Watkins^7*, Chao Zhang, PhD^7*, Jackie M. Walling, PhD, MD⁷, Athanasios C. Tsiatis, MD⁷ and Amy E. DeZern, MD⁹

¹Arthur G. James Cancer Center Hospital, The Ohio State University Comprehensive Cancer Center, Columbus, OH
²Northside Hospital Cancer Institute, Atlanta, GA
³Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR
⁴University of Texas, MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Weill Medical College of Cornell University New York-Presbyterian Hospital, New York, NY
⁷Plexxikon Inc., Berkeley, CA
⁸Daiichi Sankyo Inc., Basking Ridge, NJ
⁹Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD

Christopher Fiore, PhD^*, Michael J. Kelly, MD, MPH, MS^*, Angela Volkert^*, Li Zhou, PhD^*, Kate Madigan, MD^*, Matthew Eaton, PhD^*, Graeme Hodgson, PhD^*, David A. Roth, MD and Qing Kang-Fortner, PhD^*

Syros Pharmaceuticals, Inc., Cambridge, MA

Guillermo Garcia-Manero, MD¹, Uwe Platzbecker, MD², Stefano R. Tarantolo, MD³, Stefanie Gropper^4*, Chetasi Talati, MD⁵, Katharina S. Götze⁶, James Dugan, MD^7*, Eric S. Winer, MD⁸, Elizabeth Martinez, PhD, DHSC, MSN^9*, Christopher Lieberman^10* and Reinhard von Roemeling, MD¹¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
³Nebraska Cancer Specialist, Omaha, NE
⁴Marien Hospital Düsseldorf, Düsseldorf, Germany
⁵Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶Department of Medicine III, Technical University of Munich, Munich, Germany
⁷Novant Health at Forsyth Medical Center, Winston-Salem, NC
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
⁹Curis Inc., Lexington, MA
¹⁰Curis, Inc, Lexington, MA
¹¹Curis, Inc., Lexington, MA

David A. Sallman, MD¹, Hany Elmariah, MD, MS², Kendra L. Sweet, MD, MS^3*, Chetasi Talati, MD⁴, Asmita Mishra, MD^5*, Linda L. Kelley, PhD⁶, Amy Lankford, PhD^7*, Tim Chan, PhD^8*, Rutul R Shah^8*, Eric Padron, MD⁹, Rami S. Komrokji, MD¹⁰, Jeffrey E. Lancet, MD³, Helen Sabzevari, PhD^8*, Marco L. Davila, MD, PhD¹ and Nelli Bejanyan, MD¹¹

¹H. Lee Moffitt Cancer Center, Tampa, FL
²Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁴Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶Cell Therapy Facility, Moffitt Cancer Center, Tampa, FL
⁷Precigen, Inc., Germantown, MD
⁸Precigen, Inc, Germantown, MD
⁹Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
¹⁰H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹¹Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Weiguo Zhang, MD, PhD¹, Kyung Hee Chang, PhD^2*, Mahesh Basyal, BS^2*, Yannan Jia^2*, Lauren B Ostermann, BS^2*, William E. Fogler, PhD³, John L. Magnani, PhD³, M Anna Zal, BS., MS^2*, Tomasz Zal, PhD, MSc⁴ and Michael Andreeff, MD, PhD²

¹Section of Molecular Hematology and Therapy, Department of Leukemia, U.T.M.D. Anderson Cancer Center, Houston, TX
²Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Glycomimetics, Inc., Rockville, MD
⁴Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Brian J. Ball, MD^1*, Anthony S. Stein, MD², Gautam Borthakur, MD³, Crystal Murray, RAC^4*, Karin Kook, PhD^4*, Kyle WH Chan, PhD^5* and Eytan M. Stein, MD⁶

¹Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Pasadena, CA
²Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Salamandra, Bethesda, MD
⁵BioTheryX, Inc., San Diego, CA
⁶Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

Courtney D. DiNardo, MD, MSc¹, Daniel A. Pollyea, MD², Marina Konopleva, MD, PhD³, Kyu Hong, MS^4*, Tao Huang, PhD^5*, An Song, PhD^6*, Elizabeth Wieland, MS^7*, Paul Woodard, MD^4*, Charlene Liao, PhD^6*, Chengcheng Zhang, PhD^8*, Prapti Patel, MD⁹ and Ahmed Aribi, MD^10*

¹Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
²UCHealth University of Colorado Hospital, Denver, CO
³Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
⁴Immune-Onc Therapeutics, Inc, Palo Alto, CA
⁵Immune-Onc Therapeutics, Inc., PALO ALTO, CA
⁶Immune-Onc Therapeutics, Inc, PALO ALTO, CA
⁷Immune-Onc Therapeutics, Inc., Palo Alto, CA
⁸University of Texas-Southwestern Medical Center, Dallas, TX
⁹Simmons Comprehensive Cancer Center, Harold C Simmons Comprehensive Cancer Center, Dallas, TX
¹⁰City of Hope National Medical Center, Duarte, CA

Katharina Rothe, PhD^1,2*, Xiaojia Niu, PhD^1,2,3*, Min Chen, PhD^2*, Rick Li^4*, Sungeun Nam^5*, Xiuyan Zhang^6*, German Novakovskiy^7*, Yehyeon Ahn^8,9*, Shenshen Lai^4*, Hong Zhang, PhD^4*, Jun Yan^4*, Hong Liu^10*, Yun Zhao, PhD^6*, Depei Wu, MD, PhD¹¹, Yubin Ge, PhD^12,13,14, Wyeth W. Wasserman^9*, Calvin K. Yip^15*, Zaihui Zhang, PhD^4* and Xiaoyan Jiang, MD, PhD^1,16

¹Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
²Terry Fox Laboratory, British Columbia Cancer, Vancouver, BC, Canada
³National Engineering Laboratory for AIDS Vaccine, Key Laboratory for Molecular Enzymology and Engineering, the Ministry of Education, School of Life Sciences, Jilin University, Changchun, China
⁴SignalChem Lifesciences Corporation, Richmond, Canada
⁵Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, CAN
⁶Cyrus Tang Hematology Center, Soochow University, Suzhou, China
⁷University of British Columbia, Vancouver, BC, CAN
⁸Terry Fox Laboratory, British Columbia Cancer, Vancouver, Canada
⁹Department of Medical Genetics, University of British Columbia, Vancouver, Canada
¹⁰Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
¹¹Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
¹²Karmanos Cancer Institute Wayne State Univ., Detroit, MI
¹³Oncology, Wayne State University School of Medicine, Detroit, MI
¹⁴Molecular Therapeutics Program, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI
¹⁵Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, Canada
¹⁶Terry Fox Laboratory, BC Cancer Research Centre, Vancouver, BC, Canada

Carina Sirochinsky, BA^1*, Raymond Liang, PhD^1*, Elina Shrestha, PhD^1*, Ronen Ben Jehuda, PhD^1* and Vladislav Sandler, PhD^1,2

¹Hemogenyx Pharmaceuticals LLC, Brooklyn, NY
²Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, NY

Lina Benajiba, MD, PhD^1*, Hetty E. Carraway, MD, MBA², Nada Hamad, MB.BS, FRACP, FRCPA^3,4*, Eytan M. Stein, MD⁵, Costas K. Yannakou, MBBS (Hons), FRACP, FRCPA^6*, Amy Burroughs^7*, Scott Harris^7*, Hayley Lane^7*, Dorothy D. Nguyen, MD^7*, Monic Stuart, MD, MPH⁷, Jesse Vargas, PhD⁸, Alexandre Puissant, PhD^1*, Kimberly Stegmaier, MD⁹ and Courtney D. DiNardo, MD, MSc¹⁰

¹APHP, INSERM U944, Institute of Hematology - St Louis Hospital, PARIS, France
²Taussig Cancer Institute, Cleveland Clinic, Department of Hematology and Medical Oncology, Cleveland, OH
³Department of Haematology, St. Vincent’s Hospital, Sydney, NSW, Australia
⁴University of New South Wales, Sydney, Australia
⁵Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Department of Molecular Oncology and Cancer Immunology, Epworth HealthCare, East Melbourne, VIC, Australia
⁷Cleave Therapeutics, Inc., San Francisco, CA
⁸Cleave Therapeutics, Inc., San Diego, CA
⁹Dana-Farber Cancer Institute, Boston, MA
¹⁰Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Rebecca M Richards, MD, PhD¹, Feifei Zhao^2*, Katherine A Murphy^3*, Peng Xu, MD^4*, Amy Fan^5*, Elena Sotillo, PhD^6*, Mads Daugaard^7*, Htoo Zarni Oo^7*, Jie Liu^8*, Wan-Jen Hong⁹, Poul Sorensen^10*, Robbie G. Majzner, MD⁶, Ravi Majeti¹¹ and Crystal L. Mackall, MD¹²

¹Department of Pediatrics, Stanford University, Palo Alto, CA
²Stanford University, Stanford
³Stanford University, Palo Alto, CA
⁴Stanford University School of Medicine, Palo Alto, CA
⁵Department of Medicine, Division of Hematology, Stanford University, Stanford, CA
⁶Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA
⁷University of British Columbia, Vancouver, BC, CAN
⁸Stanford University, Stanford, CA
⁹Genentech, Inc., South San Francisco, CA
¹⁰University of British Columbia/ BC Cancer Agency Research Centre, Vancouver, BC, CAN
¹¹Department of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA
¹²Center for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, CA

Ralf Buettner, PhD¹, Le Xuan Truong Nguyen, PhD^1*, Corey James Morales, BA, BS^1*, Lisa S Chen, PhD^2*, Timothy Synold, PhD^3*, Dinh Hoa Hoang, BS^1*, Bin Amber Zhang, PhD¹, Lucy Ghoda, PhD^1*, Varsha Gandhi, PhD², Vinod A. Pullarkat, MD¹, Guido Marcucci, MD¹ and Steven T. Rosen, MD¹

¹Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
²Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Cancer Biology, City of Hope, Duarte, CA

Miaomiao Liu^1*, Yu Zhang^2*, Weiyang Zheng^1* and Qifa Liu, MD²

¹Department of Hematology, Nanfang Hospital,Southern Medical University, Guangzhou, China
²Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China

Ahmed Aribi, MD^1,2*, Anjali S Advani, MD³, William Donnellan, MD⁴, Amir T. Fathi, M.D.⁵, Marcello Rotta, MD⁶, Benjamin K. Tomlinson, MD⁷, Pankit Vachani, MD^8*, Jay Yang, MD⁹, Phoenix Ho, MD¹⁰ and Guillermo Garcia-Manero, MD¹¹

¹Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA
²City of Hope National Medical Center, Duarte, CA
³Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
⁴Tennessee Oncology / Sarah Cannon Research Institute, Nashville, TN
⁵Massachusetts General Hospital , Harvard Medical School, Cambridge, MA
⁶Sarah Cannon Blood Cancer Network, Colorado Blood Cancer Institute, Denver, CO
⁷Case Western Reserve University, Cleveland, OH
⁸University of Alabama-Birmingham, Birmingham, AL
⁹Karmanos Cancer Institute, Detroit, MI
¹⁰Seattle Genetics, Bothell, WA
¹¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Mohamed M. Hegazi, MD^1*, John G. Harpel, MD, PhD², Sara Miao^2*, Dale Ludwig, PhD^2*, Mark S. Berger, MD² and Gary J. Schiller, MD³

¹James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY
²Actinium Pharmaceuticals, Inc., New York, NY
³David Geffen School of Medicine at University of California, Los Angeles, CA

Tatsuya Masuda, Master Degree^1*, Hirohito Kubota, MD^2*, Naoya Sakuramoto, Master Degree^1*, Asuka Hada, Master Degree^1*, Ayaka Horiuchi, Master Degree^1*, Asami Sasaki, Master Degree^1*, Kanako Takeda, Master Degree^1*, Mizuho Takeda, Master Degree^1*, Hidemasa Matsuo^3*, Hiroshi Sugiyama, Ph.D.^4*, Souichi Adachi, MD, PhD⁵ and Yasuhiko Kamikubo^6*

¹Graduate School of Medicine Kyoto university, Kyoto, Japan
²Department of Pediatrics, Kyoto University Hospital, Kyoto, Japan
³Department of Human Health Sciences, Kyoto University, Kizugawa, KYO, Japan
⁴Graduate School of Chemistry,Kyoto university, Kyoto, Japan
⁵Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan
⁶Department of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan

Eytan M. Stein, MD¹, Marina Konopleva, MD, PhD², Raymond Gilmour, BSc, PhD^3*, Anna M Szpurka, PhD^3*, Elizabeth Hill, PhD^3*, Renee Ward, MD, PhD^4*, Hagop M. Kantarjian, MD² and Courtney D. Dinardo, MD, MSc²

¹Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
³Loxo Oncology at Lilly, Indianapolis, IN
⁴Loxo Oncology at Lilly, Stamford, CT